Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Biocon among top 5 biotech employers globally

Ruchika Sharma31 Oct 2020 3:22 PM IST

Bengaluru: Pharma major, Biocon Ltd, has been ranked among the Top 5 Global Biotech Employers for 2020 on the prestigious U.S. based...

Drug firm FDC launches stronger versions of Favipiravir at Rs 160 per tablet in India

Ruchika Sharma31 Oct 2020 1:00 PM IST

The 800 mg version of the drugs will help reduce the number of tablets to be taken by any patient by 75 percent, it added.

Department of Pharmaceuticals revises PLI scheme guidelines to promote domestic production of bulk drugs, medical devices

Ruchika Sharma31 Oct 2020 12:00 PM IST

New Delhi: The Department of Pharmaceuticals on Thursday revised guidelines of the Production Linked Incentive (PLI) schemes for promoting...

Boston Scientific reports loss as COVID-19 slams demand for medical devices

Ruchika Sharma31 Oct 2020 11:00 AM IST

New Delhi: Boston Scientific Corp swung to a loss in the third quarter from profit a year ago, as demand for its medical devices was hurt by the...

Speciality care, vaccines sale prompts Sanofi to raise outlook

Ruchika Sharma31 Oct 2020 9:00 AM IST

Paris: Sanofi raised its 2020 earnings guidance for the second time this year after posting slightly stronger-than-expected third-quarter results...

Zydus Cadila receives USFDA okay for Linagliptin Tablets

Ruchika Sharma30 Oct 2020 1:00 PM IST

Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received tentative approval from the US Food & Drug...

Piramal Pharma to increase Stake to 100 percent in Convergence Chemicals

Ruchika Sharma30 Oct 2020 12:30 PM IST

New Delhi: Piramal Pharma Limited (PPL), a subsidiary of Piramal Enterprises Limited (PEL), and Navin Fluorine International Limited (Navin Fluorine)...

Use of Remdesivir, Favipiravir drugs to treat COVID- 19: SC Asks Centre to clarify stand

Ruchika Sharma30 Oct 2020 12:00 PM IST

Remdesivir and Favipiravir are antiviral drugs and their efficacy in treating Covid-19 patients has been a matter of debate among medical experts.

Zydus Cadila gets USFDA nod for diabetes drug Dapagliflozin

Ruchika Sharma30 Oct 2020 11:54 AM IST

Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received tentative approval from the US Food & Drug...

Sputnik V Vaccine: Dr Reddys, Dept of Biotechnology partner for clinical trials in India

Ruchika Sharma30 Oct 2020 10:00 AM IST

Hyderabad: Drugmaker, Dr. Reddy's Laboratories Ltd., has recently announced its partnership with Biotechnology Industry Research Assistance...

Sanofi India reports net profit of Rs 133 crore in Q2

Ruchika Sharma30 Oct 2020 9:00 AM IST

New Delhi: Drug firm Sanofi India on Tuesday reported a net profit of Rs 132.9 crore for the quarter ended September 30, 2020. The company had posted...

COVID-19: Infections reported among Sputnik V trial volunteers

Ruchika Sharma29 Oct 2020 2:52 PM IST

New Delhi: There have been instances of infection among volunteers of Sputnik V trials, the world's first registered vaccine against Covid-19 virus,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok